Navigation Links
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
Date:1/30/2008

Vivian Cheung, M.D., a pediatric neurologist at The Childrens Hospital of Philadelphia and the University of Pennsylvania School of Medicine, has been named a Howard Hughes Medical Institute (HHMI) investigator. Following a nationwide competition in 2007, Cheung was one of 15 physician-scientists selected recently by the prestigious research organization.

Like all those chosen, Dr. Cheung focuses on translating research discoveries into improved medical treatments.

We are extremely pleased and proud of the fact that one of our pediatricians was honored by one of the worlds leading biomedical research institutions, said Philip R. Johnson, M.D., chief scientific officer and senior vice president of Children's Hospital. This appointment recognizes Dr. Cheungs accomplishments in advancing genetic discovery.

Cheung investigates how the sequence of DNA units in a persons chromosomes affects that persons susceptibility to disease. She uses microarray technology to rapidly measure how strongly genes are expressed within cells. By determining how gene expression changes in response to drugs and other treatments, she discovers how each patients DNA variations are associated with the effectiveness of their disease treatments.

Her goal is to help physicians predict how a patient will respond to a given drug or treatment, based on the patients particular genetic profile. Ultimately, providing refined genetic tools may remove some of the guesswork in making treatment decisions and in providing the best preventive and therapeutic care.

Trained in neurology, Cheung has a specific interest in a neurogenetic disease called ataxia telangiectasia, which affects movement, muscle control, the immune system and susceptibility to cancer. Because different children may react very differently to their treatments, her research aims to customize treatment to a patients genetic profile, thus minimizing side effects and providing maximum benefits. Cheungs studies could be applied to a broad range of common and uncommon diseases, in using genetic tools to eventually routinely guide physicians and patients to better treatments.

As a pediatrician at Childrens Hospital, Cheung is continuing to work at the Hospital and has become an employee of HHMI, which provides a research budget and funding for laboratory space. Cheung remains an associate professor of Pediatrics and Genetics at the University of Pennsylvania School of Medicine.

After earning her M.D. degree from Tufts University School of Medicine, Cheung completed her residency at the UCLA Medical Center, before coming to The Childrens Hospital of Philadelphia in 1996. She holds the William Wikoff Smith Endowed Chair in Pediatric Genomic Research at Childrens Hospital, where she leads an NIH-funded laboratory.


'/>"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Related medicine news :

1. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
2. Genetics May Determine Antidepressants Effectiveness
3. Genetics Influence Blood Pressure Medications
4. People with anorexia less likely to be blamed when biology, genetics explained
5. Top10 research advances include studies on genetics and stem cell research, stents
6. Heart attack risk from smoking due to genetics
7. Genetics May Boost Mexican-Americans Risk for Alcoholism
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
9. Researchers develop powerful tool to study the genetics of inflammation
10. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
11. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
(Date:6/26/2017)... ... June 26, 2017 , ... ... and consumers are seeing lots of red these days. According to recent estimates, ... that result from medical coding errors(1). Some studies point to Electronic Health Records ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with missing ... Cotey, with or without a referral. Dr. Cotey is a trusted dentist who has ... tooth replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged to ...
(Date:6/25/2017)... ... June 24, 2017 , ... Create a feel-good lyric music video in Final Cut ... sound in the timeline and write in the lyrics to any song. ProLyric flies in ... Each line of the text can be added modularly for optimal control. ProLyric makes editing ...
(Date:6/25/2017)... ... ... An increase in wetter weather in the Northern California area naturally means ... humdinger of an allergy season. A relief from drought conditions is most welcome, but ... weed pollen. , “Our patients have been reporting the typical allergy season symptoms, ...
(Date:6/25/2017)... ... ... a heatwave currently bearing down on Northern California pushing temperatures to the maximum, many people ... easy with laser hair removal. , The process of summer waxing and constantly shaving ... you want to do is get out, dive in and cool off. There is a ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... , June 16, 2017  Exactly 50 years ago ... off what later became known as the San Francisco "Summer ... ) is unveiling two radical innovations in strategic market research ... This announcement marks the beginning of Northern Light,s "Summer of ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
Breaking Medicine Technology: